Analytical Control · Reproducibility · Compliance Framework
SAFFRON PHARMA® applies a structured quality model focused on reproducibility, not isolated peak performance.
Quality is defined by stability across batches and seasons.
Quality Philosophy
The program does not pursue maximum pigment once.
It pursues repeatable pigment every cycle.
Compound stability across harvest seasons is prioritised over single-batch fluctuation.
Industrial credibility requires parameter predictability.
Drying & Stabilisation Protocol
Quality control begins at post-harvest handling.
Standard protocol includes:
- manual stigma separation
- controlled airflow drying (30–40°C)
- avoidance of thermal degradation
- post-drying moisture verification
- dark, humidity-controlled storage
Rapid dehydration or uncontrolled heating is excluded.
Batch Analytical Screening
Each batch may undergo:
- moisture verification
- visual stigma integrity assessment
- preliminary heavy metal screening
- organoleptic verification
Advanced batches proceed to:
- ISO 3632 profiling
- crocin quantification
- picrocrocin assessment
- safranal monitoring
Only reproducible batches qualify for structured supply.
Microbiological & Safety Panel
For pharmaceutical-oriented lots, screening may include:
- Total Plate Count
- Yeasts & Molds
- E. coli absence
- Salmonella absence
- Aflatoxin panel
- Heavy metal quantification
Testing scope is defined by destination market requirements.
Reproducibility Tracking
The program maintains internal tracking of:
- batch-to-batch compound variation
- multi-season stability
- drying-variable impact
- climatic influence on phytochemical profile
Scaling decisions are based on stability data, not volume demand.
Storage & Stability
Post-drying storage follows:
- low-humidity environment
- light exclusion
- hermetic packaging
- controlled temperature conditions
Long-term stability monitoring is integrated into quality assessment.
Compliance Orientation
The objective is EU-aligned botanical raw material readiness.
Future scaling includes:
- expanded laboratory documentation
- structured COA issuance
- traceability-linked compliance records
- GMP-compatible handling infrastructure (development stage)
Quality Commitment
SAFFRON PHARMA® operates under a structured validation-first model.
No batch is released for structured supply without:
- moisture compliance
- visual integrity
- safety screening
- internal reproducibility evaluation
Quality precedes expansion.